Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen E Langabeer

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
JAK-STAT|September 29, 2015
JAK2 mutations to the fore in hereditary thrombocythemiaStephen E Langabeer
Quantitative Imaging in Medicine and Surgery|October 12, 2018
Incidental abnormal bone marrow signal on magnetic resonance imaging and reflexive testing for the <i>JAK2</i> V617F mutationStephen E Langabeer
American Journal of Clinical Pathology|December 21, 2023
Noncanonical CALR variantsStephen E Langabeer
EXCLI Journal|July 9, 2020
Can post-splenectomy thrombocytosis mask essential thrombocythaemia?Stephen E Langabeer
Irish Journal of Medical Science|July 9, 2020
Reduction in molecular diagnostics of myeloproliferative neoplasms during the COVID-19 pandemicStephen E Langabeer
Blood Cells, Molecules & Diseases|October 27, 2019
The role of a low erythropoietin level in the diagnosis of JAK2 exon 12-mutated polycythemia veraStephen E Langabeer
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 4, 2026
Should <i>JAK2</i> V617F Mutation Testing be Inducted into Routine Thrombophilia Screening?Stephen E Langabeer
Virchows Archiv : an International Journal of Pathology|November 1, 2025
Langerhans cell sarcoma and myeloproliferative neoplasms: close or distant relatives?Stephen E Langabeer
Respiratory Medicine and Research|December 19, 2025
Screening for an underlying myeloproliferative neoplasm in patients with chronic thromboembolic pulmonary hypertensionStephen E Langabeer
Archives of Medical Research|January 21, 2025
Comment on "Features and Allele Frequency of JAK2 exon 12-mutated Polycythemia Vera in Comparison with JAK2 V617F-mutated Disease"Stephen E Langabeer
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
JAK-STAT|September 29, 2015
JAK2 mutations to the fore in hereditary thrombocythemiaStephen E Langabeer
Quantitative Imaging in Medicine and Surgery|October 12, 2018
Incidental abnormal bone marrow signal on magnetic resonance imaging and reflexive testing for the <i>JAK2</i> V617F mutationStephen E Langabeer
American Journal of Clinical Pathology|December 21, 2023
Noncanonical CALR variantsStephen E Langabeer
EXCLI Journal|July 9, 2020
Can post-splenectomy thrombocytosis mask essential thrombocythaemia?Stephen E Langabeer
Irish Journal of Medical Science|July 9, 2020
Reduction in molecular diagnostics of myeloproliferative neoplasms during the COVID-19 pandemicStephen E Langabeer
Blood Cells, Molecules & Diseases|October 27, 2019
The role of a low erythropoietin level in the diagnosis of JAK2 exon 12-mutated polycythemia veraStephen E Langabeer
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 4, 2026
Should <i>JAK2</i> V617F Mutation Testing be Inducted into Routine Thrombophilia Screening?Stephen E Langabeer
Virchows Archiv : an International Journal of Pathology|November 1, 2025
Langerhans cell sarcoma and myeloproliferative neoplasms: close or distant relatives?Stephen E Langabeer
Respiratory Medicine and Research|December 19, 2025
Screening for an underlying myeloproliferative neoplasm in patients with chronic thromboembolic pulmonary hypertensionStephen E Langabeer
Archives of Medical Research|January 21, 2025
Comment on "Features and Allele Frequency of JAK2 exon 12-mutated Polycythemia Vera in Comparison with JAK2 V617F-mutated Disease"Stephen E Langabeer
Pageof 17